APA (7th ed.) Citation

J, S., G, T., I, V., N, K., L, W., P, L., . . . D, A. (2026). Impact of donor and recipient EBV serostatus on transplant outcomes in patients with acute leukemia after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: Infectious Diseases Working Party EBMT retrospective study. Bone marrow transplantation, 61(7), 941. https://doi.org/10.1038/s41409-026-02898-x

Chicago Style (17th ed.) Citation

J, Styczynski, et al. "Impact of Donor and Recipient EBV Serostatus on Transplant Outcomes in Patients with Acute Leukemia After Haploidentical Hematopoietic Cell Transplantation with Post-transplant Cyclophosphamide: Infectious Diseases Working Party EBMT Retrospective Study." Bone Marrow Transplantation 61, no. 7 (2026): 941. https://doi.org/10.1038/s41409-026-02898-x.

MLA (9th ed.) Citation

J, Styczynski, et al. "Impact of Donor and Recipient EBV Serostatus on Transplant Outcomes in Patients with Acute Leukemia After Haploidentical Hematopoietic Cell Transplantation with Post-transplant Cyclophosphamide: Infectious Diseases Working Party EBMT Retrospective Study." Bone Marrow Transplantation, vol. 61, no. 7, 2026, p. 941, https://doi.org/10.1038/s41409-026-02898-x.